Courses:
F02: Geriatric Mental Health Disorder Management (1 CE, .5 RX, 1 G)
F06: Dementia Assessment with the SLUMS Test (1 CE, 1 RX, .5 G, 1 E/J)
F07: Substance Use Trends in Youth (1 CE, .5 E/J)
F08: Menopause and Cardiometabolic Wellness (1 CE, 1 RX)
F10: Stroke Impact: Care Burden and Caregiver Strain (1 CE, .5 RX, .5 G, 1 O)
F11: Pediatric Mental Health in Texas (1 CE, 1 RX)
F12: T1.5 Diabetes Mellitus and Hypercortisolism (1 CE, 1 RX, .5 G)
S13: COPD: Pathophysiology and Clinical Practice (1 CE, .5 RX, .5 G)
S16: Deprescribing Strategies for Older Adults (1 CE, 1 RX, 1 G)
S17: Congestive Heart Failure with Preserved Ejection Fraction (1 CE, .5 RX)
S19: Pediatric Vaccination and Disease Prevention (1 CE, 1 RX)
S27: Trauma-Informed Care in Clinical Practice Provider (1 CE, .25 E/J)

Texas Nurse Practitioners is approved as a provider of nursing continuing professional development by Louisiana State Nurses Association - Approver, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. If you are required to use an activity number or provider number on certificates, please use LSNA Provider N003232 

 Stephanie Hoelscher
EBSCO DynaAI AI advisory board member (compensated,
still active).
•  Shelagh Larson
Organon’s NEXPLANON subdermal contraceptive device,
trainer. This will impact this talk.
Astellas’ VEOZAH non-hormonal hot flash medication,
speaker. No conflicts of interest with this talk.
•  Jessica Peck
Sanofi, Speaker’s Bureau, Pediatric RSV immunization.
•  Terri DeNeui
1. Spouse is the owner and CEO of a 503B manufacturing pharmacy and a 503A compounding pharmacy (Farmakieo).
2. Speaker is the founder of a training and marketing company with a focus on hormone replacement (EVEXIAS
Health Solutions).
All listed above will be resolved via Nurse Planner review of presentation slides. No other relevant financial relationships exist for presenters or planners of this conference.